VNDA
Vanda Pharmaceuticals Inc. · Healthcare
President and CEO Mihael Hristos Polymeropoulos sold $1.3M of Vanda Pharmaceuticals Inc.
Sold$1,276,971
$8.17Price
156,235Shares
−5%Stake
What VNDA did after the filing
- The stock from Wed, Mar 4 close, $8.20
- −12.7%
- S&P 500, same days
- +2.4%
Measured over 30 trading days, to the Apr 16 close.
Traded Mon, Mar 2. Filed Wed, Mar 4, 1:51 PM ET, during the session. Returns use the Mar 4 close and the Apr 16 close. Not investment advice.